HEADER TRANSFERASE 12-MAY-14 4D2S TITLE HUMAN TTK IN COMPLEX WITH A DYRK1B INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 512-795; COMPND 5 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE, PYT; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, ONCOLOGY EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI,J.G.KETTLE,P.BALLARD,C.BARDELLE,S.BUTTERWORTH, AUTHOR 2 N.COLCLOUGH,S.E.CRITCHLOW,G.FAIRLEY,S.FILLERY,M.A.GRAHAM,L.GOODWIN, AUTHOR 3 S.GUICHARD,K.HUDSON,A.MAHMOOD,J.VINCENT,R.A.WARD,D.WHITTAKER REVDAT 2 23-OCT-19 4D2S 1 AUTHOR REMARK REVDAT 1 22-APR-15 4D2S 0 JRNL AUTH J.G.KETTLE,P.BALLARD,C.BARDELLE,M.COCKERILL,N.COLCLOUGH, JRNL AUTH 2 S.E.CRITCHLOW,J.E.DEBRECZENI,G.FAIRLEY,S.FILLERY,M.A.GRAHAM, JRNL AUTH 3 L.GOODWIN,S.GUICHARD,K.HUDSON,R.A.WARD,D.WHITTAKER JRNL TITL DISCOVERY AND OPTIMIZATION OF A NOVEL SERIES OF DYRK1B JRNL TITL 2 KINASE INHIBITORS TO EXPLORE A MEK RESISTANCE HYPOTHESIS. JRNL REF J.MED.CHEM. V. 58 2834 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25738750 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00098 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 13748 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 984 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.59 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2530 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1827 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2405 REMARK 3 BIN R VALUE (WORKING SET) : 0.1812 REMARK 3 BIN FREE R VALUE : 0.2141 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.94 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 125 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1903 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.82900 REMARK 3 B22 (A**2) : -1.95390 REMARK 3 B33 (A**2) : 0.12490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.238 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.228 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.179 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.206 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.172 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.903 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2436 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3301 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 844 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 59 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 351 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2436 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 304 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3078 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.44 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.96 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|985 - A|1082 } REMARK 3 ORIGIN FOR THE GROUP (A): 21.8758 -4.8564 60.8002 REMARK 3 T TENSOR REMARK 3 T11: 0.1645 T22: 0.0035 REMARK 3 T33: -0.0095 T12: 0.0406 REMARK 3 T13: 0.0065 T23: 0.0789 REMARK 3 L TENSOR REMARK 3 L11: 2.3045 L22: 1.0987 REMARK 3 L33: 1.6214 L12: -0.1003 REMARK 3 L13: -0.3771 L23: -0.3569 REMARK 3 S TENSOR REMARK 3 S11: -0.0538 S12: -0.2134 S13: -0.2757 REMARK 3 S21: 0.2296 S22: -0.0557 S23: -0.1053 REMARK 3 S31: 0.4450 S32: 0.2322 S33: 0.1096 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|1083 - A|1286 } REMARK 3 ORIGIN FOR THE GROUP (A): 14.3601 9.0773 39.5309 REMARK 3 T TENSOR REMARK 3 T11: -0.0472 T22: -0.0300 REMARK 3 T33: -0.0692 T12: 0.0027 REMARK 3 T13: 0.0114 T23: -0.0077 REMARK 3 L TENSOR REMARK 3 L11: 1.9810 L22: 0.8840 REMARK 3 L33: 0.9950 L12: -0.1293 REMARK 3 L13: 0.3172 L23: -0.1093 REMARK 3 S TENSOR REMARK 3 S11: -0.0085 S12: 0.2393 S13: -0.0583 REMARK 3 S21: 0.0068 S22: -0.0098 S23: 0.0921 REMARK 3 S31: -0.0212 S32: 0.0002 S33: 0.0183 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4D2S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1290060610. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13748 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 27.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.6100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG3350, 5% ETHANOL, 0.1M NA REMARK 280 CITRATE PH 6, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.51900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.51900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 54.00650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.67600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 54.00650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 56.67600 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 35.51900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 54.00650 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 56.67600 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 35.51900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 54.00650 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 56.67600 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 512 REMARK 465 LYS A 617 REMARK 465 SER A 618 REMARK 465 ASN A 669 REMARK 465 GLN A 670 REMARK 465 MET A 671 REMARK 465 GLN A 672 REMARK 465 PRO A 673 REMARK 465 ASP A 674 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 GLN A 683 REMARK 465 VAL A 684 REMARK 465 GLY A 685 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 LYS A 710 REMARK 465 ILE A 711 REMARK 465 GLN A 794 REMARK 465 THR A 795 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 523 CZ NH1 NH2 REMARK 470 GLU A 545 CG CD OE1 OE2 REMARK 470 LYS A 546 CG CD CE NZ REMARK 470 LYS A 547 CG CD CE NZ REMARK 470 GLN A 548 CG CD OE1 NE2 REMARK 470 GLU A 558 CG CD OE1 OE2 REMARK 470 GLU A 559 CG CD OE1 OE2 REMARK 470 GLN A 563 CG CD OE1 NE2 REMARK 470 ASP A 566 OD1 OD2 REMARK 470 LYS A 577 CD CE NZ REMARK 470 GLN A 580 CG CD OE1 NE2 REMARK 470 ARG A 587 CD NE CZ NH1 NH2 REMARK 470 LYS A 614 CG CD CE NZ REMARK 470 LYS A 615 CE NZ REMARK 470 LYS A 616 CG CD CE NZ REMARK 470 TRP A 622 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 622 CZ3 CH2 REMARK 470 GLU A 623 CG CD OE1 OE2 REMARK 470 LYS A 625 CD CE NZ REMARK 470 LYS A 696 CG CD CE NZ REMARK 470 GLN A 736 CG CD OE1 NE2 REMARK 470 ILE A 738 CG1 CG2 CD1 REMARK 470 GLN A 740 CG CD OE1 NE2 REMARK 470 ILE A 741 CG1 CG2 CD1 REMARK 470 LEU A 744 CG CD1 CD2 REMARK 470 HIS A 745 CG ND1 CD2 CE1 NE2 REMARK 470 ILE A 748 CG1 CG2 CD1 REMARK 470 ASP A 749 CG OD1 OD2 REMARK 470 ASN A 751 CG OD1 ND2 REMARK 470 GLU A 753 CG CD OE1 OE2 REMARK 470 GLU A 755 CG CD OE1 OE2 REMARK 470 LYS A 762 CG CD CE NZ REMARK 470 LYS A 769 CG CD CE NZ REMARK 470 LYS A 777 CG CD CE NZ REMARK 470 GLN A 778 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 515 50.39 -98.42 REMARK 500 ILE A 586 130.42 -38.37 REMARK 500 SER A 646 -25.84 68.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DYK A 1794 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D2R RELATED DB: PDB REMARK 900 HUMAN IGF IN COMPLEX WITH A DYRK1B INHIBITOR DBREF 4D2S A 512 795 UNP P33981 TTK_HUMAN 512 795 SEQRES 1 A 284 GLY ALA ALA ASN GLU CYS ILE SER VAL LYS GLY ARG ILE SEQRES 2 A 284 TYR SER ILE LEU LYS GLN ILE GLY SER GLY GLY SER SER SEQRES 3 A 284 LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS GLN ILE TYR SEQRES 4 A 284 ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA ASP ASN GLN SEQRES 5 A 284 THR LEU ASP SER TYR ARG ASN GLU ILE ALA TYR LEU ASN SEQRES 6 A 284 LYS LEU GLN GLN HIS SER ASP LYS ILE ILE ARG LEU TYR SEQRES 7 A 284 ASP TYR GLU ILE THR ASP GLN TYR ILE TYR MET VAL MET SEQRES 8 A 284 GLU CYS GLY ASN ILE ASP LEU ASN SER TRP LEU LYS LYS SEQRES 9 A 284 LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SER TYR TRP SEQRES 10 A 284 LYS ASN MET LEU GLU ALA VAL HIS THR ILE HIS GLN HIS SEQRES 11 A 284 GLY ILE VAL HIS SER ASP LEU LYS PRO ALA ASN PHE LEU SEQRES 12 A 284 ILE VAL ASP GLY MET LEU LYS LEU ILE ASP PHE GLY ILE SEQRES 13 A 284 ALA ASN GLN MET GLN PRO ASP THR THR SER VAL VAL LYS SEQRES 14 A 284 ASP SER GLN VAL GLY THR VAL ASN TYR MET PRO PRO GLU SEQRES 15 A 284 ALA ILE LYS ASP MET SER SER SER ARG GLU ASN GLY LYS SEQRES 16 A 284 SER LYS SER LYS ILE SER PRO LYS SER ASP VAL TRP SER SEQRES 17 A 284 LEU GLY CYS ILE LEU TYR TYR MET THR TYR GLY LYS THR SEQRES 18 A 284 PRO PHE GLN GLN ILE ILE ASN GLN ILE SER LYS LEU HIS SEQRES 19 A 284 ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU PHE PRO ASP SEQRES 20 A 284 ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU LYS CYS CYS SEQRES 21 A 284 LEU LYS ARG ASP PRO LYS GLN ARG ILE SER ILE PRO GLU SEQRES 22 A 284 LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN THR HET DYK A1794 32 HETNAM DYK N-{2-METHOXY-4-[(1-METHYLPIPERIDIN-4-YL)OXY]PHENYL}-4- HETNAM 2 DYK (1H-PYRROLO[2,3-C]PYRIDIN-3-YL)PYRIMIDIN-2-AMINE FORMUL 2 DYK C24 H26 N6 O2 FORMUL 3 HOH *2(H2 O) HELIX 1 1 ASP A 561 GLN A 579 1 19 HELIX 2 2 LEU A 609 LYS A 615 1 7 HELIX 3 3 ASP A 620 GLN A 640 1 21 HELIX 4 4 LYS A 649 ALA A 651 5 3 HELIX 5 5 PRO A 691 ASP A 697 1 7 HELIX 6 6 PRO A 713 GLY A 730 1 18 HELIX 7 7 ASN A 739 ASP A 749 1 11 HELIX 8 8 GLU A 761 LEU A 772 1 12 HELIX 9 9 SER A 781 LEU A 786 1 6 HELIX 10 10 HIS A 788 ILE A 793 1 6 SHEET 1 AA 6 CYS A 517 VAL A 520 0 SHEET 2 AA 6 ARG A 523 GLY A 534 -1 O ARG A 523 N VAL A 520 SHEET 3 AA 6 SER A 537 LEU A 543 -1 O SER A 537 N GLY A 534 SHEET 4 AA 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542 SHEET 5 AA 6 TYR A 597 MET A 602 -1 O ILE A 598 N VAL A 555 SHEET 6 AA 6 LEU A 588 ILE A 593 -1 N TYR A 589 O VAL A 601 SHEET 1 AB 3 ILE A 607 ASP A 608 0 SHEET 2 AB 3 PHE A 653 VAL A 656 -1 N ILE A 655 O ILE A 607 SHEET 3 AB 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656 SITE 1 AC1 11 ILE A 531 ALA A 551 LYS A 553 GLU A 603 SITE 2 AC1 11 GLY A 605 ASN A 606 ILE A 607 ASP A 608 SITE 3 AC1 11 SER A 611 LEU A 654 ILE A 663 CRYST1 108.013 113.352 71.038 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009258 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008822 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014077 0.00000